Monopar Therapeutics
MNPR
#8266
Rank
HK$1.46 B
Marketcap
HK$240.37
Share price
0.42%
Change (1 day)
540.05%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2024 (TTM): -HK$50.55 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$65.3 Million, an increase over its 2022 earnings that were of -HK$81.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$50.55 Million-22.59%
2023 -HK$65.3 Million-20.1%
2022 -HK$81.73 Million15.52%
2021 -HK$70.75 Million44.39%
2020 -HK$49 Million49.23%
2019 -HK$32.84 Million28.04%
2018 -HK$25.65 Million-80.07%
2017 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.12 Billion 2,106.96%๐Ÿ‡บ๐Ÿ‡ธ USA